Guillermo Albericio

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

J. López-Barneo, R. Ramírez-Lorca, A. Pascual, 2023, Nature Neuroscience.

Highly attenuated poxvirus-based vaccines against emerging viral diseases

L. Marcos-Villar, J. García-Arriaza, B. Perdiguero, 2023, Journal of molecular biology.

Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection

M. Esteban, J. García-Arriaza, J. Casasnovas, 2022, Frontiers in Immunology.

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

J. Lasarte, M. Esteban, J. García-Arriaza, 2023, Frontiers in Immunology.

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases

L. Marcos-Villar, J. García-Arriaza, B. Perdiguero, 2023, Journal of Molecular Biology.

Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection.

A. Gómez-Carballa, F. Martinón-Torres, I. Rivero-Calle, 2023, Antiviral research.

Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates

J. García-Arriaza, J. Casasnovas, P. Sánchez-Cordón, 2023, Frontiers in Immunology.

Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2

R. Godoy-Ruiz, K. Adipietro, L. Álvarez-Vallina, 2023, Advanced science.